Integrow Health SA

Low Dose Naltrexone

Precision Immune & Pain Support

sub-lingual dosing for inflammation, immune balance & wellness

Low dose naltrexone

Overview: Product Description

Our Low-Dose Naltrexone (LDN) Spray is designed for targeted, convenient support of immune regulation, chronic pain relief, inflammation control, sleep and mood – all in a smart sub-lingual format. In a world where so many people struggle with unresolved pain, autoimmune stress, persistent fatigue or dysregulated sleep and mood, this unique formulation offers a low-dose pathway to help your body recalibrate. Delivered as a spray under the tongue, LDN at low microgram/milligram levels bypasses much of first-pass liver metabolism, allowing for gentler, more predictable absorption – making it ideal for long-term wellness, chronic conditions and maintenance support.

Why LDN?

Many people today experience chronic pain, persistent inflammation, autoimmune challenges, disrupted sleep/mood and immune imbalance. Conventional high-dose treatments may carry side-effects, and standard opioid antagonists or immunomodulators are not always suitable for long-term wellness. The research literature shows that low-dose naltrexone (LDN) can act differently to higher-dose therapy – modulating microglial activation, immune signalling and inflammation pathways rather than simply blocking opioid receptors. At Integrow Health we recognised the gap: a precision, well-absorbed sub-lingual format that allows lower doses with better bioavailability and fewer side-effects, providing the foundation for better chronic-support strategies.

"In tiny doses, Naltrexone boosts the production of endorphins in the brain."

Benefits

  • Supports immune modulation and helps restore immune balance in chronic conditions.
  • Relieves persistent pain, particularly where inflammation or central sensitisation are involved.
  • Addresses low-grade neuro-inflammation by inhibiting microglial activation in the central nervous system.
  • Promotes improved sleep, better mood stability and overall wellness thanks to modulation of endorphin/endorphin-like pathways.
  • Convenient oral-spray format allows for precise dosing, excellent absorption, and bypasses much of liver metabolism (tablet losses) – aligning with modern wellness lifestyles.

More Advantages

  • Affordable and accessible compared to many long-term prescription alternatives.
  • Well absorbed via sub-lingual spray: estimated >80% absorption compared with high first-pass loss in oral tablets.
  • Flexible dosing options: Plain, Peppermint flavour, Very Low dose, Ultra Low dose – meaning we can tailor to your sensitivity, condition and response.
  • Low side-effect profile compared with high-dose antagonists and many immunomodulatory drugs, making it suitable for ongoing use and wellness maintenance.
  • Shelf-stable, compact spray bottle (9 ml) fits easily into daily routines meaning no large pills, no injections, no complex administration.

Supplement Profile

  • Naltrexone (Low Dose / Very Low Dose / Ultra Low Dose): The primary active. At low doses, naltrexone acts as a non-selective opioid receptor antagonist (µ, κ, δ) but more importantly in this context: modulates microglial (central nervous system immune) activation, toll-like receptor 4 (TLR4) pathways, and the opioid growth factor–opioid growth factor receptor (OGF-OGFr) axis.
  • Serving Size: 1 spray under the tongue (approximate; dosage depends on variant)
  • Servings per Container: ~60 sprays per 9 ml bottle (varies slightly by variant)
  • Format: Oral sub-lingual spray, 9 ml refill bottle
  • Packaging: 9 ml plastic spray bottle (shrink-wrapped), shelf-ready
  • Active Ingredient per Serving (approximate):
    • LDN (Standard strength) – most common variant:  refer label
    • VLDN (Very Low Dose) – 200 µg (0.2 mg) of naltrexone per spray.
  • Purified water
  • Flavour (peppermint)
  • Present: None reported
  • Not Present: Gluten, dairy, soy, nuts, shellfish
  • Keto: Yes 
  • Dairy: No
  • Fish: No
  • Pork: No
  • Pregnancy & breastfeeding: Consult your healthcare professional before use. There is limited published safety data for low‐dose naltrexone in pregnancy or lactation.
  • Age restrictions: Not intended for children unless prescribed by a qualified medical practitioner.
  • As naltrexone is an opioid‐receptor antagonist, it may precipitate withdrawal in individuals actively using opioids.
  • Use caution if you have severe liver dysfunction (naltrexone in higher doses is hepatically metabolised—though low dose may mitigate risk).
  • Potential interactions with opioid analgesics (may reduce their effect) – always consult your doctor.
  • Side Effects: At low doses the side-effect profile is relatively mild, but may include sleep disturbance (especially if taken late), vivid dreams, fatigue or dizziness.
  • Store in a cool, dry place below 25 °C.
  • Protect from direct sunlight and heat.
  • Keep the bottle tightly closed when not in use.
  • Keep out of reach of children.
  • Some variants (e.g., Very Low Dose) are recommended to be refrigerated for best stability, though room temperature storage is acceptable for short term.

Directions

  • For the VLDN version (Very Low Dose) – each spray delivers 200 µg (0.2 mg) of naltrexone, approximately 60 sprays per bottle.
  • For standard LDN Spray – dosage may vary; follow label instructions.
  • Timing: Many users take the spray at bedtime between 18:00-22:00, to align with endorphin modulation and to avoid potential insomnia if taken later.
  • How to take: Spray under the tongue (or inside the cheek), hold for 30-60 seconds without swallowing immediately, then swallow. Do not eat, drink or brush teeth immediately before or after use to maximise absorption.
  • Initial adjustment period: For first 3 days some users begin before noon to test tolerance (especially with VLDN). From Day 4 onward, evening dosing is recommended for sleep/mood alignment.
  • Note: Do not exceed the recommended number of sprays unless instructed by your practitioner. Monitor your response, adjust timing if sleep disturbance occurs.

Low-Dose Naltrexone operates via several complementary mechanisms:

  1. Microglial modulation & TLR4 antagonism: At low doses, naltrexone antagonises Toll-Like Receptor 4 (TLR4) on microglial cells in the central nervous system, reducing neuro-inflammation, central sensitisation and chronic pain signalling.
  2. Transient opioid-receptor blockade → endogenous endorphin rebound: By briefly blocking µ-opioid receptors, the body responds by increasing production of endogenous opioids (endorphins and enkephalins), which support mood, natural pain relief and immune balance.
  3. OGF-OGFr axis modulation (in some uses): Low-dose naltrexone may inhibit the opioid growth factor–opioid growth factor receptor axis, which influences cell proliferation, immune signalling and may have applications in auto-immune and oncologic support.
  4. Improved absorption via sub-lingual spray: The Integrow formulation bypasses much first-pass hepatic metabolism (tablet naltrexone can lose >80% in liver). The spray format supports faster entry, more predictable blood levels and fewer metabolites that may cause side-effects.

Together, these mechanisms mean the formulation acts not simply as a passive blocker, but as a modulator of immune/inflammatory/endorphin systems – aligning with chronic-support and wellness orientation rather than acute high‐dose antagonism.

  • Individuals experiencing persistent or unexplained chronic pain, fibromyalgia, central sensitisation and inflammatory pain syndromes.
  • People with auto-immune conditions, low-grade inflammation, immune balance challenges or those interested in immune-resilience support.
  • Anyone who struggles with sleep disturbance, mood swings or headaches and wants a gentle modulator rather than heavy pharmaceutical therapy.
  • Wellness-oriented users who prefer non-pill, convenient formats (spray) and want a long-term support strategy rather than a short-term fix.
  • Adults (18+) seeking to optimise overall immune function, inflammation balance and holistic wellbeing.

🌿 Tailored dosing formats: Choose from Standard LDN, Very Low Dose (VLDN) or Ultra Low Dose (ULDN) – in Plain or Peppermint flavour – so every individual can find their ideal strength and tolerance.

💧 Superior absorption: Our sub-lingual spray format bypasses the digestive tract for rapid uptake and better bioavailability, avoiding the heavy first-pass loss that comes with tablets.

💰 Affordable & long-lasting: Each 9 ml bottle gives around 60 precision sprays, providing up to two months of use – excellent value with no waste.

🌙 Gentle & well-tolerated: Because of its low micro-dosing and efficient absorption, side-effects are minimal, making LDN suitable for long-term wellness and maintenance.

🧬 Science-driven innovation: Grounded in clinical evidence from Medscape and PubMed, LDN works through proven pathways like TLR4 modulation and endorphin balance to support immune regulation and inflammation control.

🌱 Holistic wellness philosophy: As part of the Integrow Health approach, this product supports your whole-body vitality — combining precision science with natural synergy.

🔍 Transparency you can trust: Clear labelling, dosing guidance, and medical disclaimers ensure safe, informed and responsible use.

Science

  • A 2018 review concluded that LDN “can act as an immunomodulator in multiple autoimmune diseases and malignant tumours as well as alleviate the symptoms of some mental disorders.” PubMed

  • A 2018 Medscape article reported that at much lower doses (1.5-12 mg) naltrexone appears to function as an anti-inflammatory agent in the central nervous system, via microglial modulation. Medscape

  • A 2025 meta-analysis of seven randomised trials found LDN may reduce pain in chronic pain syndromes by blocking TLR4 and preventing central sensitisation. PubMed

  • A 2024 review in Cancer highlighted LDN’s inhibitory effect on cancer cell proliferation via the OGF-OGFr axis, suggesting value as an adjuvant to conventional therapy. MDPI

  • A 2023 study examined long-term effects of LDN on adipose-derived mesenchymal stem cells and demonstrated changes in immunomodulatory gene expression, supporting its systemic immune impact. PubMed
    Note: While promising, LDN remains off-label for many uses and large-scale robust clinical trials are still limited; always consult your medical provider.

Reviews

Chronic pain relief

30/06/2025

This is working for my chronic pain. I am going to be consistent in taking this for 6 months to fully realise its pain reduction potential. Thank you Integrow.

Richard T.

Energy increase

12/03/2025

Amazing product, I can feel the difference in my energy levels.

Lizette V.

Auto-immune help

27/11/2024

I use LDN for my auto-immune (Hashimotos). It helps to keep the immune response in check, reduces overall body aches and definitely helps with brain fog/anxiety. The customer service at Integrow is world class.

Yolandi S.

Inflammation relief

22/11/2024

Love the spray application. Would highly recommend. Instantly works for inflammation in my experience.

Trevlyn D.

Depression support

06/11/2024

I am steadily weaning myself of my antidepressant and switching over to LDN. What a great product

Melissa G.

Your Wellness,
Re-balanced

Support your immune balance, reduce inflammation, and feel your best with Integrow’s precision-formulated Low-Dose Naltrexone Spray.
Scroll to Top